Related Experiment Videos
Current concepts on interstitial lung disease in children.
1James Whitcomb Riley Hospital for Children, Indiana University School of Medicine, Indianapolis 46202-5225, USA.
Current Opinion in Pediatrics
|June 1, 1999
Summary
Pediatric interstitial lung disease (ILD) is a rare, complex group of lung disorders in children. Research is ongoing to understand its causes, improve diagnosis, and develop targeted therapies to reduce serious illness and death.
Area of Science:
- Pediatric Pulmonology
- Rare Diseases
- Respiratory Medicine
Background:
- Pediatric interstitial lung disease (ILD) encompasses rare conditions affecting lung development and function in children.
- Unlike adults, children require ongoing lung growth, complicating ILD management and prognosis.
- Current knowledge regarding pathogenesis, prognosis, and treatment of pediatric ILD remains limited.
Purpose of the Study:
- To investigate the cellular mediators and genetic factors contributing to interstitial lung damage in children.
- To further define the various types of pediatric ILD and diagnostic modalities.
- To advance the development of targeted therapies for pediatric ILD.
Main Methods:
- Focus on defining cellular mediators of interstitial damage.
- Investigating the role of viral infections and genetic predispositions.
- Evaluating diagnostic tools including bronchoalveolar lavage, radiography, and biopsy.
Main Results:
- Ongoing research aims to elucidate the underlying mechanisms of pediatric ILD.
- Studies are refining the classification and diagnostic approaches for these rare conditions.
- Efforts are directed towards identifying specific therapeutic targets.
Conclusions:
- Understanding the unique challenges of pediatric ILD, including lung development, is crucial.
- Multidisciplinary research is essential for improving diagnosis and treatment outcomes.
- The ultimate goal is to reduce the significant morbidity and mortality associated with pediatric ILD.